M. Azizi et al., Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients, J HYPERTENS, 18(8), 2000, pp. 1139-1147
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background Additive hemodynamic effects of combined blockade of the renin-a
ngiotensin system by an angiotensin I converting enzyme inhibitor and an an
giotensin II antagonist have been observed in sodium-depleted normotensive
volunteers and in patients with congestive heart failure.
Objective To investigate whether the same additive hemodynamic effects occu
r in patients with hypertension and to verify the safety of such an approac
h.
Design Multicenter, randomized, double-blind, parallel-group, pilot study.
Patients 177 patients with mild-to-moderate hypertension [diastolic blood p
ressure (DBP): 95-115 mmHg after a 4-week placebo run-in period] were inclu
ded in the study.
Intervention Combination therapy consisting of 50 mg losartan daily and 10
mg enalapril daily was administered for 6 weeks. The effects of this therap
eutic regimen was compared with similar groups of patients who received eit
her 50 mg losartan daily or 10 mg enalapril daily
Main outcome measures 24-hour ambulatory mean DBP and clinic DBP measured a
t trough after 6 weeks of treatment.
Results 24-hour ambulatory mean DBP did not significantly differ between tr
eatment groups although the combination tended to lower BP more. The combin
ation therapy was more effective on clinic DBP measured at trough than was
losartan by 3.2 mmHg [confidence interval (95%, CI) 0.7-5.7 mmHg, P = 0.012
], and more effective than enalapril by 4.0 mmHg (95% CI, 1.5-6.4 mmHg, P =
0.002). In a subgroup of 28 patients, higher plasma active renin and angio
tensin I levels during blockade by the combination therapy were observed. T
his finding confirmed that the combination of the two agents inhibited the
renin-angiotensin system to a greater extent than did either agent alone.
Conclusion A combination of 10 mg enalapril daily and 50 mg losartan daily
safely induces a supplementary, although modest, fall in clinic DBP in pati
ents with mild-to-moderate essential hypertension. J Hypertens 2000, 18:113
9-1147 (C) Lippincott Williams & Wilkins.